Evidence map›Paper›PMID 35542301›Full record

ArticleRSC advances2019

The effects of trace metal impurities on Ga-68-radiolabelling with a tris(3-hydroxy-1,6-dimethylpyridin-4-one) (THP) chelator.

Ruslan Cusnir, Andrew Cakebread, Margaret S Cooper, Jennifer D Young, Philip J Blower, Michelle T Ma

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Minimising the impact of stableEJNMMI radiopharmacy and chemistry · 2025
    Article
  3. Pharmaceutics · 2025
    Review
  4. Good practices forEJNMMI radiopharmacy and chemistry · 2022
    Review
  5. Review
  6. Cold Kit Labeling: The Future ofFrontiers in medicine · 2022
    Review
  7. [Bioconjugate chemistry · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Ruslan CusnirSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK michelle.ma@kcl.ac.uk.
Andrew CakebreadMass Spectrometry Facility, King's College London Franklin Wilkins Building, 150 Stamford St London SE1 9NH UK.
Margaret S CooperSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK michelle.ma@kcl.ac.uk.
Jennifer D YoungSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK michelle.ma@kcl.ac.uk.
Philip J BlowerSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0001-6290-1590
Michelle T MaSchool of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital London SE1 7EH UK michelle.ma@kcl.ac.uk.ORCID https://orcid.org/0000-0002-3349-7346
St Thomas' Hospital · GBKing's College London · GB

Funding

Cancer Research UK 24959Wellcome Trust
6 · The paper itself

Abstract

GMP-grade

Identifiers

PMID35542301
PMCPMC9075519
OpenAlexW2983379295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.